CompletedPhase 3ACTRN12611000405910

Does using progesterone in threatened miscarriage increase the live birth rate?

In women with threatened miscarriage, does progesterone supplementation increase the likelihood of live birth?

Sponsor

Dr Luke McLindon

Enrollment

386 participants

Start Date

Feb 8, 2012

Study Type

Interventional

Conditions

Threatened Miscarriage

Summary

This project will assess the effect of progesterone therapy on pregnancy outcomes in women presenting with threatened miscarriage. It is hypothesised that progesterone supplementation for early threatened pregnancy increases the live birth rate.

Eligibility

Sex: FemalesMin Age: 18 Yearss

Plain Language Summary

Simplified for easier understanding

This study tests whether giving progesterone to women experiencing a threatened miscarriage (vaginal bleeding in early pregnancy) can increase the chance of a successful live birth. It is for women aged 18+ with a confirmed live pregnancy under 10 weeks who did not conceive through assisted reproductive technologies.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Progesterone pessary 400 mg nightly, until 12 weeks + 0 days

Locations(1)

QLD, Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12611000405910

Related Trials

Biochemical, 2D and 3D Ultrasonographic Predictors of Pregnancy Outcome in Women With Threatened Abortion

NCT067975571 location